NewsRx

Search our medical news database

Cancer Risk Factors

Elevated risk of second cancer after breast cancer may justify screening

Published in Women's Health Weekly, December 1st, 2005

An elevated risk of second cancer after breast cancer may justify screening for breast, ovarian, and colon cancer in some groups.

Researchers in The Netherlands sought "to assess the risk of second primary cancers among women with previous breast cancer and calculate the excess burden of second cancer in the population. A population-based longitudinal study was conducted using the Eindhoven cancer registry data on 9,919 breast cancer patients diagnosed in the period 1972-2000 and followed until 2001."

I. Soerjomataram and colleagues calculated "standardized incidence ratios (SIR) and absolute excess risks (AER). In total, 1298 (13%) women developed a...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook